A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC
Vložit
- čas přidán 20. 07. 2023
- A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC
Chair, Pasi A. Jänne, MD, PhD, discusses NSCLC in this CME/MOC activity titled “A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC: The Latest Evidence and Practical Guidance for Biomarker Testing and Individualized Treatment Selection and Sequencing.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/AYJ865. CME/MOC credit will be available until July 18, 2024.
